Second Generation Small Molecule Inhibitors of Botulinum Neurotoxins
Second Generation Small Molecule Inhibitors of Botulinum Neurotoxins
批准号:
8525316
负责人:
Sina Bavari
金额:
$89.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-25 至 2014-08-31
关键词:
3-DimensionalAddressAerosolsAnimal ModelAsphyxiaBacteriaBiologicalBiological AssayBiological TestingBontoxilysinBotulinum Toxin Type ABotulismCategoriesCenters for Disease Control and Prevention (U.S.)Cessation of lifeChemicalsClostridium botulinumCritical CareCytosolDatabasesDoseEnzymesFoodGenerationsGeneric DrugsGoalsIn VitroInhibitory Concentration 50InstructionIntoxicationLeadLightLiquid substanceMechanical ventilationMethodsMiningMolecular ModelsMusNational SecurityNeuronsOrganic ChemistryParalysedPeptide HydrolasesPharmaceutical PreparationsPlanetsPoisoningPrincipal InvestigatorProcessPublic HealthReproduction sporesRouteSerotypingSolidStructure-Activity RelationshipTextTherapeuticTimeToxic effectToxinTranslatingX-Ray CrystallographyZincbasebiothreatbotulinum toxin type Bbotulinum toxin type Ehigh throughput screeningin vivoinhibitor/antagonistmolecular modelingnovelpharmacophoreprophylacticsmall moleculevesicle-associated membrane protein
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Botulinum neurotoxins (BoNTs) represent one of the most serious bioterror threats to our national security. Secreted by spore forming bacteria Clostridium botulinum, baratii, and butyricium, BoNTs are responsible for the flaccid paralysis associated with botulism. Listed as category A biothreats by the CDC, BoNTs are the most toxic of biological toxins, are easily produced, and may be delivered by various routes including food spiking (solid and liquid) and aerosol dispersion. There are no therapeutics to counter BoNT induced paralysis once the enzyme has entered the neuronal cytosol - at this time the only treatment option is impractical mechanical ventilation in a critical care setting. The long-term objective of this project is to address this public health threat by developing potent small molecule, non-peptidic, inhibitors (SMNPIs) of BoNTs as therapeutics that will serve as both rescue agents and prophylactics. Specific aims 1 - 3 of the proposal focus on translating our lead uM range SMNPIs of BoNT serotype A into low nM range SMNPIs that are effective in an animal model. Specific aim 4 concentrates on identifying and developing SMNPIs of BoNT serotype B that are effective in a neuronal assay, and specific aim 5 covers the identification of SMNPIs of BoNT serotype E. Finally, under specific aim 6, we propose examining all identified and developed SMNPIs for broad spectrum inhibitory activity against more than one BoNT serotype. To achieve the project goals we combine three-dimensional pharmacophore-based methods and synthetic organic chemistry strategies. Specifically, such methods combine X-ray crystallography, in vitro and in vivo biological testing, molecular modeling and 3-D database mining, and organic chemistry to guide SMNPI discovery and optimization (i.e., good in vitro potencies, good ADMET profiles, reduced toxicities, and enhanced in vivo efficacies in an animal model). RELEVANCE (See instructions): Botulinum neurotoxins (BoNTs) are the most potent toxins on the planet and are capable of being used as bioterror devises. There is currently no therapeutic to counter the inevitable suffocation and certain death resulting from the paralysis induced by BoNT poisoning. We propose the use of therapeutically viable chemicals as drugs. Our proposal includes molecules that already possess activity against critical components of the BoNT intoxication process for two serotypes.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Novel therapeutic uses and formulations of botulinum neurotoxins: a patent review (2012 - 2014).
肉毒杆菌神经毒素的新治疗用途和配方:专利审查(2012 - 2014 年)。
DOI:
10.1517/13543776.2015.1030337
发表时间:
2015
期刊:
Expert opinion on therapeutic patents
影响因子:
6.6
作者:
[Kane,ChristopherD, Nuss,JonathanE, Bavari,Sina]
通讯作者:
Bavari,Sina
DOI:
10.1021/jm500033r
发表时间:
2014-05-22
期刊:
Journal of medicinal chemistry
影响因子:
7.3
作者:
[Videnović M, Opsenica DM, Burnett JC, Gomba L, Nuss JE, Selaković Z, Konstantinović J, Krstić M, Segan S, Zlatović M, Sciotti RJ, Bavari S, Solaja BA]
通讯作者:
Solaja BA
4-Amino-7-chloroquinolines: probing ligand efficiency provides botulinum neurotoxin serotype A light chain inhibitors with significant antiprotozoal activity.
4-氨基-7-氯喹啉:探测配体效率,提供具有显着抗原虫活性的肉毒杆菌神经毒素血清型 A 轻链抑制剂。
DOI:
10.1021/jm4006077
发表时间:
2013
期刊:
Journal of medicinal chemistry
影响因子:
7.3
作者:
[Opsenica,IgorM, Tot,Mikloš, Gomba,Laura, Nuss,JonathanE, Sciotti,RichardJ, Bavari,Sina, Burnett,JamesC, Solaja,BogdanA]
通讯作者:
Solaja,BogdanA
DOI:
10.1021/bc200330m
发表时间:
2012-01-18
期刊:
BIOCONJUGATE CHEMISTRY
影响因子:
4.7
作者:
[Novakovic, Irena, Andelkovic, Uros, Zlatovic, Mario, Gasic, Miroslav J., Sladic, Dusan]
通讯作者:
Sladic, Dusan
DOI:
10.1016/j.ejmech.2012.03.043
发表时间:
2012-07
期刊:
European journal of medicinal chemistry
影响因子:
6.7
作者:
[Opsenica I, Filipovic V, Nuss JE, Gomba LM, Opsenica D, Burnett JC, Gussio R, Solaja BA, Bavari S]
通讯作者:
Bavari S
Targeting Cellular Processes to Counter the Effects of BoNT Intoxication
-
批准号:8366888
-
项目类别:
-
资助金额:$15.54万
-
财政年份:2012
-
负责人:Sina Bavari
-
依托单位:
Targeting Cellular Processes to Counter the Effects of BoNT Intoxication
-
批准号:8473162
-
项目类别:
-
资助金额:$18.36万
-
财政年份:2012
-
负责人:Sina Bavari
-
依托单位:
Targeting Cellular Processes to Counter the Effects of BoNT Intoxication
-
批准号:9094670
-
项目类别:
-
资助金额:$36.88万
-
财政年份:2012
-
负责人:Sina Bavari
-
依托单位:
Targeting Cellular Processes to Counter the Effects of BoNT Intoxication
-
批准号:8841460
-
项目类别:
-
资助金额:$37.77万
-
财政年份:2012
-
负责人:Sina Bavari
-
依托单位:
Second Generation Small Molecule Inhibitors of Botulinum Neurotoxins
-
批准号:7938770
-
项目类别:
-
资助金额:$86.66万
-
财政年份:2009
-
负责人:Sina Bavari
-
依托单位:
Second Generation Small Molecule Inhibitors of Botulinum Neurotoxins
-
批准号:8137145
-
项目类别:
-
资助金额:$95.68万
-
财政年份:2009
-
负责人:Sina Bavari
-
依托单位:
Second Generation Small Molecule Inhibitors of Botulinum Neurotoxins
-
批准号:8316320
-
项目类别:
-
资助金额:$95.45万
-
财政年份:2009
-
负责人:Sina Bavari
-
依托单位:
Second Generation Small Molecule Inhibitors of Botulinum Neurotoxins
-
批准号:7644602
-
项目类别:
-
资助金额:$81.48万
-
财政年份:2009
-
负责人:Sina Bavari
-
依托单位:
海外基金